Proinflammatory Activation of Monocytes in Patients with Immunoinflammatory Rheumatic Diseases
- PMID: 39002011
- DOI: 10.1134/S1607672924700959
Proinflammatory Activation of Monocytes in Patients with Immunoinflammatory Rheumatic Diseases
Abstract
The pathogenesis of immunoinflammatory rheumatic diseases (IRDs) is based on chronic inflammation, one of the key mechanisms of which may be abnormal activation of macrophages, leading to further disruption of the immune system.
Objective: . The objective of this study was to evaluate the proinflammatory activation of circulating monocytes in patients with IRDs.
Materials and methods: . The study involved 149 participants (53 patients with rheumatoid arthritis (RA), 45 patients with systemic lupus erythematosus (SLE), 34 patients with systemic scleroderma (SSc), and 17 participants without IRDs) 30 to 65 years old. Basal and lipopolysaccharide (LPS)-stimulated secretion of monocytes was studied in a primary culture of monocytes obtained from blood by immunomagnetic separation. Quantitative assessment of the cytokines tumor necrosis factor α (TNF-α), interleukin 1β (IL-1β), as well as the chemokine monocyte chemoattractant protein-1 (MCP-1) was carried out in the culture fluid by ELISA. Proinflammatory activation of monocytes was calculated as the ratio of LPS-stimulated and basal secretions.
Results: . It was shown that the basal secretion of all studied cytokines was significantly increased in all groups of patients with IRDs, except for the secretion of IL-1β in the SLE group, compared to the control. LPS-stimulated secretion of TNF-α was increased and MCP-1 was decreased in patients with IRDs compared to the control group; LPS-stimulated IL-1β secretion only in the SSc group significantly differed from the control group. In the RA group, monocyte activation was reduced for all cytokines compared to the control; in the SLE group, for TNF-α and MCP-1; in the SSc group, for MCP-1.
Conclusions: . The decrease in proinflammatory activation of monocytes in patients with IRDs is due to a high level of basal secretion of cytokines, which can lead to disruption of the adequate immune response in these diseases and is an important link in the pathogenesis of chronic inflammation.
Keywords: IL-1β; MCP-1; TNF-α; monocyte activation; proinflammatory cytokines; rheumatoid arthritis; systemic lupus erythematosus; systemic scleroderma.
© 2024. Pleiades Publishing, Ltd.
Similar articles
-
Inflammatory Response of Monocytes/Macrophages in Patients with Systemic Sclerosis.Front Biosci (Landmark Ed). 2024 Jul 22;29(7):259. doi: 10.31083/j.fbl2907259. Front Biosci (Landmark Ed). 2024. PMID: 39082361
-
Effect of pro-inflammatory/anti-inflammatory agents on cytokine secretion by peripheral blood mononuclear cells in rheumatoid arthritis and systemic lupus erythematosus.Autoimmunity. 2003 Mar;36(2):71-7. doi: 10.1080/0891693031000079275. Autoimmunity. 2003. PMID: 12820688
-
Identification of activated cytokine pathways in the blood of systemic lupus erythematosus, myositis, rheumatoid arthritis, and scleroderma patients.Int J Rheum Dis. 2012 Feb;15(1):25-35. doi: 10.1111/j.1756-185X.2011.01654.x. Epub 2011 Aug 31. Int J Rheum Dis. 2012. PMID: 22324944
-
Monocytes in rheumatoid arthritis: Circulating precursors of macrophages and osteoclasts and, their heterogeneity and plasticity role in RA pathogenesis.Int Immunopharmacol. 2018 Dec;65:348-359. doi: 10.1016/j.intimp.2018.10.016. Epub 2018 Oct 23. Int Immunopharmacol. 2018. PMID: 30366278 Review.
-
Thyroid disease as a comorbidity in inflammatory rheumatic diseases.Rheumatol Int. 2025 Feb 11;45(3):46. doi: 10.1007/s00296-025-05798-3. Rheumatol Int. 2025. PMID: 39932596 Review.
Cited by
-
Extra Virgin Olive Oil Polyphenol-Enriched Extracts Exert Antioxidant and Anti-Inflammatory Effects on Peripheral Blood Mononuclear Cells from Rheumatoid Arthritis Patients.Antioxidants (Basel). 2025 Jan 31;14(2):171. doi: 10.3390/antiox14020171. Antioxidants (Basel). 2025. PMID: 40002358 Free PMC article.
References
REFERENCES
-
- Kouchit, Ya., Morand, L., and Martis, N., Mortality and its risk factors in critically ill patients with connective tissue diseases: a meta-analysis, Eur. J. Intern. Med., 2022, vol. 98, pp. 83–92. https://doi.org/10.1016/j.ejim.2022.02.006 - DOI - PubMed
-
- Nasonov, E.L., Lila, A.M., Dubinina, T.V., Nikininskaya, O.A., and Amirdjanova, V.N., Advances in rheumatology at the beginning of the 21st century, Nauchno-Prakt. Revmatol., 2022, vol. 60, no. 1, pp. 5–20. https://doi.org/10.47360/1995-4484-2022-5-20 - DOI
-
- Ahsan, H., Selfie: autoimmunity, boon or bane, J. Immunoassay Immunochem., 2017, vol. 38, no. 3, pp. 235–246. https://doi.org/10.1080/15321819.2017.1319861 - DOI - PubMed
-
- Yang, Sh., Zhao, M., and Jia, S., Macrophage: key player in the pathogenesis of autoimmune diseases, Front. Immunol., 2023, vol. 14, p. 1080310. https://doi.org/10.3389/fimmu.2023.1080310
-
- Nasonov, E.L. and Avdeeva, A.S., Interleukin 18 in immune-mediated rheumatic diseases and COVID-19, Nauchno-Prakt. Revmatol., 2022, vol. 60, no. 2, pp. 195–204. https://doi.org/10.47360/1995-4484-2022-195-204 - DOI
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous